Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Major histocompatibility system in multiple sclerosis]

J Oger, O Sabouraud, R Fauchet

    Revue Neurologique
    |February 1, 1976
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Progressive multiple sclerosis exhibits decreasing glutamate and glutamine over two years.

    Multiple sclerosis (Houndmills, Basingstoke, England)·2015
    Same author

    Beta-interferon exposure and onset of secondary progressive multiple sclerosis.

    European journal of neurology·2015
    Same author

    Investigation of heterogeneity in the association between interferon beta and disability progression in multiple sclerosis: an observational study.

    European journal of neurology·2013
    Same author

    'Clinically definite benign multiple sclerosis', an unwarranted conceptual hodgepodge: evidence from a 30-year observational study.

    Multiple sclerosis (Houndmills, Basingstoke, England)·2012
    Same author

    Survival in MS: a randomized cohort study 21 years after the start of the pivotal IFNβ-1b trial.

    Neurology·2012
    Same author

    A phase III study evaluating the efficacy and safety of MBP8298 in secondary progressive MS.

    Neurology·2011
    Same journal

    Geographic disparities in MRI features of ischemic stroke and small vessel disease: A comparative study between French Guiana and mainland France. Findings from the BECATOUR multicenter registry.

    Revue neurologique·2026
    Same journal

    Continuous subcutaneous perfusion of apomorphine in Parkinson's disease: Towards monotherapy?

    Revue neurologique·2026
    Same journal

    Neuro-Whipple presenting as autoimmune encephalitis.

    Revue neurologique·2026
    Same journal

    Multimodal assessment of minimally conscious state and cognitive motor dissociation in neurocritical care: A critical review.

    Revue neurologique·2026
    Same journal

    Development of a new episodic memory assessment tool (NEM): Preliminary data and clinical perspectives.

    Revue neurologique·2026
    Same journal

    Novel variants and rare clinical presentations in MFN2-related Charcot-Marie-Tooth disease: Insights from 10 families.

    Revue neurologique·2026
    See all related articles

    Histocompatibility testing reveals increased HL-A7 and HL-A8, with decreased HL-A12 in multiple sclerosis (MS) patients. Specific immune response genes may be linked to MS pathogenesis.

    Area of Science:

    • Immunogenetics
    • Human Leukocyte Antigens (HLA) research
    • Neuroimmunology

    Context:

    • Multiple Sclerosis (MS) is an autoimmune disease affecting the central nervous system.
    • Histocompatibility antigens (HLA) play a crucial role in immune regulation.
    • Previous studies suggested associations between specific HLA types and MS susceptibility.

    Purpose:

    • To investigate the association between specific Human Leukocyte Antigen (HLA) types and Multiple Sclerosis (MS).
    • To compare HLA antigen frequencies in MS patients versus healthy controls.
    • To explore the role of immune response genes in MS.

    Summary:

    • A study compared HLA antigen profiles in 82 MS patients and 368 controls.
    • Confirmed increased frequencies of HL-A7 and HL-A8, and decreased HL-A12 in MS patients.

    Related Experiment Videos

  • Mixed Lymphocyte Reaction (MLR) indicated a significant increase in LD7a, strongly associated with HL-A7 positive individuals.

    • Impact:

    • Provides evidence for a genetic predisposition to MS linked to specific HLA alleles.
    • Suggests the involvement of immune response genes in the development of Multiple Sclerosis.
    • Highlights HL-A7 and LD7a as potential biomarkers for MS susceptibility or disease mechanisms.